Cargando…

Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib

Hepatocellular Carcinoma (HCC) is increasing in incidence worldwide and requires new approaches to therapy. The combination of anti-angiogenic drug therapy and radiotherapy is one promising new approach. The anti-angiogenic drug vandetanib is a tyrosine kinase inhibitor of vascular endothelial growt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Znati, Sami, Carter, Rebecca, Vasquez, Marcos, Westhorpe, Adam, Shahbakhti, Hassan, Prince, Jessica, Vlckova, Petra, De Vellis, Chiara, Bascal, Zainab, Loizidou, Marilena, Sharma, Ricky A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408860/ https://www.ncbi.nlm.nih.gov/pubmed/32668592 http://dx.doi.org/10.3390/cancers12071878

Ejemplares similares

Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer
por: Carter, Rebecca, et al.
Publicado: (2019)

Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes
por: Carter, R, et al.
Publicado: (2016)

Vandetanib-eluting Radiopaque Beads: In vivo Pharmacokinetics, Safety and Toxicity Evaluation following Swine Liver Embolization
por: Denys, Alban, et al.
Publicado: (2017)

Vandetanib
por: Vozniak, J. Michael, et al.
Publicado: (2012)

VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver Malignancies
por: Beaton, Laura, et al.
Publicado: (2019)

Apoferritin/Vandetanib Association Is Long-Term Stable But Does Not Improve Pharmacological Properties of Vandetanib
por: Jáklová, Kateřina, et al.
Publicado: (2021)

Long‐term cardiovascular effects of vandetanib and pazopanib in normotensive rats
por: Cooper, Samantha L., et al.
Publicado: (2019)

Stevens-Johnson Syndrome Induced by Vandetanib
por: Yoon, Jimi, et al.
Publicado: (2011)

Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers
por: Liew, Lydia P., et al.
Publicado: (2023)

Radiopaque drug-eluting embolisation beads as fiducial markers for stereotactic liver radiotherapy
por: Beaton, Laura, et al.
Publicado: (2022)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
por: Degrauwe, Nils, et al.
Publicado: (2012)

Role of vandetanib in the management of medullary thyroid cancer
por: Brassard, Maryse, et al.
Publicado: (2012)

Selective use of vandetanib in the treatment of thyroid cancer
por: Fallahi, Poupak, et al.
Publicado: (2015)

Dermoscopic findings of perifollicular pigmentation associated with vandetanib
por: Cury-Martins, Jade, et al.
Publicado: (2018)

Investigating the effect of vandetanib and celecoxib combination on angiogenesis
por: Qadir, Abdul, et al.
Publicado: (2023)

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair
por: Groselj, B, et al.
Publicado: (2013)

Radiosensitisation and radioprotection by BSO and WR-2721: the role of oxygenation.
por: Durand, R. E., et al.
Publicado: (1989)

The role of apoptotic cell death in the radiosensitising effect of gemcitabine
por: Pauwels, B, et al.
Publicado: (2009)

The role of mitochondrial function in gold nanoparticle mediated radiosensitisation
por: Taggart, Laura E, et al.
Publicado: (2014)

Cell cycle specific radiosensitisation by the disulfiram and copper complex
por: Tesson, Mathias, et al.
Publicado: (2017)

Metformin is a metabolic modulator and radiosensitiser in rectal cancer
por: Buckley, Croí E., et al.
Publicado: (2023)

Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
por: Deshpande, Hari, et al.
Publicado: (2011)

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers
por: Harrington, K J, et al.
Publicado: (2011)

Cytotoxicity and radiosensitising activity of synthesized dinitrophenyl derivatives of 5-fluorouracil
por: Abdi, Khosrou, et al.
Publicado: (2012)

Titanium Dioxide Nanoparticles as Radiosensitisers: An In vitro and Phantom-Based Study
por: Youkhana, Esho Qasho, et al.
Publicado: (2017)

Low-energy electrons transform the nimorazole molecule into a radiosensitiser
por: Meißner, Rebecca, et al.
Publicado: (2019)

Bound Electron Enhanced Radiosensitisation of Nimorazole upon Charge Transfer
por: Kumar, Sarvesh, et al.
Publicado: (2022)

Photosensitivity Reactions to Vandetanib: Redevelopment after Sequential Treatment with Docetaxel
por: Son, Young-Min, et al.
Publicado: (2011)

Pharmacokinetic Drug Interactions with Vandetanib during Coadministration with Rifampicin or Itraconazole
por: Martin, Paul, et al.
Publicado: (2012)

Vandetanib induced phototoxic reaction progressed to toxic epidermal necrolysis()
por: Gul, Busra Demirbag, et al.
Publicado: (2022)

Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells
por: van Bree, C, et al.
Publicado: (2008)

Bcl-x(L) antisense oligonucleotides radiosensitise colon cancer cells
por: Wacheck, V, et al.
Publicado: (2003)

Comparative study of the radiosensitising and cell cycle effects of vinflunine and vinorelbine, in vitro
por: Simoens, Cindy, et al.
Publicado: (2008)

Radiosensitising effect of electrochemotherapy with bleomycin in LPB sarcoma cells and tumors in mice
por: Kranjc, Simona, et al.
Publicado: (2005)

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression()
por: Groselj, Blaz, et al.
Publicado: (2013)

The Impact of p53 Dysfunction in ATR Inhibitor Cytotoxicity and Chemo- and Radiosensitisation
por: Middleton, Fiona K., et al.
Publicado: (2018)

Inhibition of glycolysis and mitochondrial respiration promotes radiosensitisation of neuroblastoma and glioma cells
por: Nile, Donna L., et al.
Publicado: (2021)

Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer
por: Deshpande, Hari, et al.
Publicado: (2011)

A secondary RET mutation in the activation loop conferring resistance to vandetanib
por: Nakaoku, Takashi, et al.
Publicado: (2018)

Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes
por: Fallahi, Poupak, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o9i9u69r1jgi4fkqsoce84l32m